Literature DB >> 24218361

The immune system and head and neck squamous cell carcinoma: from carcinogenesis to new therapeutic opportunities.

Monika E Freiser1, Paolo Serafini, Donald T Weed.   

Abstract

Head and neck squamous cell carcinomas (HNSCCs) exhibit complex interactions with the host immune system that may simultaneously explain resistance to various therapeutic modalities and that may also provide opportunities for therapeutic intervention. Discoveries in immunologic research over the last decade have led to an increased understanding of these interactions as well as the development of a multitude of investigational immunotherapies. Here, we describe the interaction between HNSCC and the immune system, including a discussion of immune cells involved with tumor carcinogenesis and the role of immune-modulating factors derived from tumors. We also describe the current immunotherapeutic approaches being investigated for HNSCC, including a discussion of the successes and limitations. With this review, we hope to present HNSCC as a model to guide future research in cancer immunology.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24218361     DOI: 10.1007/s12026-013-8462-3

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   4.505


  194 in total

1.  Increased recurrence and metastasis in patients whose primary head and neck squamous cell carcinomas secreted granulocyte-macrophage colony-stimulating factor and contained CD34+ natural suppressor cells.

Authors:  M R Young; M A Wright; Y Lozano; M M Prechel; J Benefield; J P Leonetti; S L Collins; G J Petruzzelli
Journal:  Int J Cancer       Date:  1997-02-20       Impact factor: 7.396

2.  Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients.

Authors:  S A Rosenberg; M T Lotze; J C Yang; P M Aebersold; W M Linehan; C A Seipp; D E White
Journal:  Ann Surg       Date:  1989-10       Impact factor: 12.969

3.  Increased protein nitrosylation in head and neck squamous cell carcinogenesis.

Authors:  B G Bentz; G K Haines; J A Radosevich
Journal:  Head Neck       Date:  2000-01       Impact factor: 3.147

4.  COX-2 expression in dysplasia of the head and neck: correlation with elF4E.

Authors:  C A Nathan; I L Leskov; M Lin; F W Abreo; R Shi; G H Hartman; J Glass
Journal:  Cancer       Date:  2001-10-01       Impact factor: 6.860

Review 5.  Nitric oxide and the immune response.

Authors:  C Bogdan
Journal:  Nat Immunol       Date:  2001-10       Impact factor: 25.606

6.  Vascular endothelial growth factor in squamous cell head and neck carcinoma: expression and prognostic significance.

Authors:  P Salven; P Heikkilä; A Anttonen; M Kajanti; H Joensuu
Journal:  Mod Pathol       Date:  1997-11       Impact factor: 7.842

Review 7.  GM-CSF-based cancer vaccines.

Authors:  Glenn Dranoff
Journal:  Immunol Rev       Date:  2002-10       Impact factor: 12.988

Review 8.  Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion.

Authors:  Robert D Schreiber; Lloyd J Old; Mark J Smyth
Journal:  Science       Date:  2011-03-25       Impact factor: 47.728

9.  Molecular mechanisms of treg-mediated T cell suppression.

Authors:  Angelika Schmidt; Nina Oberle; Peter H Krammer
Journal:  Front Immunol       Date:  2012-03-21       Impact factor: 7.561

10.  Recurrent oral cancer: current and emerging therapeutic approaches.

Authors:  Sabrina Daniela da Silva; Michael Hier; Alex Mlynarek; Luiz Paulo Kowalski; Moulay A Alaoui-Jamali
Journal:  Front Pharmacol       Date:  2012-07-30       Impact factor: 5.810

View more
  14 in total

1.  Immune responses of dendritic cells combined with tumor-derived autophagosome vaccine on hepatocellular carcinoma.

Authors:  Yongxiang Yi; Jianbo Han; Liang Zhao; Chunying Wang; Yuan Fang; Qiang Wei; Liang Hu; Junmao Liu; Yufeng Zhang; Lili Wang
Journal:  Chin J Cancer Res       Date:  2015-12       Impact factor: 5.087

2.  Anti-CD47 treatment enhances anti-tumor T-cell immunity and improves immunosuppressive environment in head and neck squamous cell carcinoma.

Authors:  Lei Wu; Guang-Tao Yu; Wei-Wei Deng; Liang Mao; Lei-Lei Yang; Si-Rui Ma; Lin-Lin Bu; Ashok B Kulkarni; Wen-Feng Zhang; Lu Zhang; Zhi-Jun Sun
Journal:  Oncoimmunology       Date:  2018-03-13       Impact factor: 8.110

3.  Tadalafil reduces myeloid-derived suppressor cells and regulatory T cells and promotes tumor immunity in patients with head and neck squamous cell carcinoma.

Authors:  Donald T Weed; Paolo Serafini; Jennifer L Vella; Isildinha M Reis; Adriana C De la Fuente; Carmen Gomez; Zoukaa Sargi; Ronen Nazarian; Joseph Califano; Ivan Borrello
Journal:  Clin Cancer Res       Date:  2014-10-15       Impact factor: 12.531

4.  Therapeutic antitumor efficacy of tumor-derived autophagosome (DRibble) vaccine on head and neck cancer.

Authors:  Hang Su; Qiong Luo; Hao Xie; Xiaofeng Huang; Yanhong Ni; Yongbin Mou; Qingang Hu
Journal:  Int J Nanomedicine       Date:  2015-03-10

5.  Selective blockade of B7-H3 enhances antitumour immune activity by reducing immature myeloid cells in head and neck squamous cell carcinoma.

Authors:  Liang Mao; Teng-Fei Fan; Lei Wu; Guang-Tao Yu; Wei-Wei Deng; Lei Chen; Lin-Lin Bu; Si-Rui Ma; Bing Liu; Yansong Bian; Ashok B Kulkarni; Wen-Feng Zhang; Zhi-Jun Sun
Journal:  J Cell Mol Med       Date:  2017-04-11       Impact factor: 5.310

6.  Blockade of adenosine A2A receptor enhances CD8+ T cells response and decreases regulatory T cells in head and neck squamous cell carcinoma.

Authors:  Si-Rui Ma; Wei-Wei Deng; Jian-Feng Liu; Liang Mao; Guang-Tao Yu; Lin-Lin Bu; Ashok B Kulkarni; Wen-Feng Zhang; Zhi-Jun Sun
Journal:  Mol Cancer       Date:  2017-06-07       Impact factor: 27.401

7.  Profiling dendritic cell subsets in head and neck squamous cell tonsillar cancer and benign tonsils.

Authors:  Milad Abolhalaj; David Askmyr; Christina Alexandra Sakellariou; Kristina Lundberg; Lennart Greiff; Malin Lindstedt
Journal:  Sci Rep       Date:  2018-05-23       Impact factor: 4.379

Review 8.  Targeting Cellular Metabolism Modulates Head and Neck Oncogenesis.

Authors:  Yi-Ta Hsieh; Yi-Fen Chen; Shu-Chun Lin; Kuo-Wei Chang; Wan-Chun Li
Journal:  Int J Mol Sci       Date:  2019-08-14       Impact factor: 5.923

9.  Characterisation and prognostic value of tertiary lymphoid structures in oral squamous cell carcinoma.

Authors:  Anna M Wirsing; Oddveig G Rikardsen; Sonja E Steigen; Lars Uhlin-Hansen; Elin Hadler-Olsen
Journal:  BMC Clin Pathol       Date:  2014-08-23

10.  Neutrophil-lymphocyte ratio complements volumetric staging as prognostic factor in patients treated with definitive radiotherapy for oropharyngeal cancer.

Authors:  Cédric Panje; Oliver Riesterer; Christoph Glanzmann; Gabriela Studer
Journal:  BMC Cancer       Date:  2017-09-11       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.